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Malaria is an infectious disease caused by the parasite Plasmodium that is 
transmitted by mosquitoes. It is estimated that malaria causes 1.1 million deaths 
per year globally. While anti-malarial drugs have been effective in treating 
infected individuals, new methodologies are needed. Treatments may benefit 
from approaches that encapsulate drugs in vehicles allowing for more effective 
delivery. To this end, the use of targeted drug delivery vehicles called filomicelles 
to treat malaria is proposed. 
  
Certain amphiphilic diblock copolymers self-assemble into filomicelles (long and 
stable cylindrical micelles), which are capable of carrying hydrophobic drugs in 
the bodies of rodents. It is shown in this dissertation that the surface of these 
filomicelles can be covalently modified with peptides. The peptides have been 
found by other research groups to bind apical membrane antigen 1 (AMA1) of 
malaria parasites. AMA1 is part of the machinery that allows Plasmodium to 
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CHAPTER I  
INTRODUCTION AND GENERAL INFORMATION 
 
1.1 Significance  
 
 Malaria is an infection transmitted via mosquitoes carrying the causative 
protozoan, Plasmodium. Much of the early work of the Centers for Disease 
Control and Prevention (CDC), created in 1946, was to concentrate on the 
control and elimination of malaria in the United States. With the successful 
reduction of malaria in the United States, the CDC now focuses on malaria 
prevention, surveillance, and technical support both domestically and 
internationally. While no longer a major problem in the United States, malaria 
infection remains a major threat to half of the world’s population. According to the 
World Health Organization, between the years of 2000 and 2010 malaria caused 
an estimate of 1.1 million deaths per year, inflicting both adults and children.  
Current attempts in limiting the infection involve prophylactic treatments, 
insecticides, environmental measures in eliminating the parasite-bearing 
mosquitoes, and use of protective netting in shielding against mosquitoes.  
However, drug resistance has become a major concern with the emergence of 
both drug resistant mosquitoes and parasite. Chloroquine, for example, is an 
anti-malarial drug used historically for malaria prophylaxis since the 1940s, but it 
is no longer recommended by the CDC in travelers to many areas of the world 
because the parasites have gained resistance to chloroquine [31].  Additionally, 
other protective measures are not always practical or possible in other countries.  
As a result, malaria remains a major global health issue. As of 2011, malaria is 
endemic to more than 100 countries and territories.     
1.2 Innovation 
  
 Drug delivery vehicles have shown promise in improving the treatments of 
several diseases. I have developed a drug delivery vehicle based on the 
template of filomicelles with the aim of improving the treatment of malaria. 
 
 Filomicelles are similar to worm-like micelles in their structure and 
flexibility but are longer (lengths of microns as opposed to tens-of-nanometers) 
and more stable [8]. They have a widely used poly(ethylene-oxide) (PEO) 
surface chemistry that can be modified with cell-targeting peptides and can be 
readily viewed with fluorescent microscopy. As a result of these unique physical 
properties, filomicelles are emerging as alternate vehicles to more traditional 
carriers such as liposomes. 
 
 Previous work on filomicelles focused on reducing the mass of epithelial-
based tumors [6]. In that work, filomicelles were loaded with the anti-cancer drug 
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paclitaxel (TAX) and injected into mice bearing xenographs. The filomicelles 
shrunk the size of the tumor over shorter carriers and freely circulating TAX. 
 
 In that study, the filomicelles were not targeted to the tumor – that is, no 
biomolecules were conjugated to the exteriors of the filomicelles that had affinity 
for the tumor cells. It was postulated that the filomicelles localized to the tumor 
because of leaky vasculature characteristic of solid mass tumors [20]. 
Nanoparticles with modification for specific targeting have also been shown to be 
new promising drug delivery approach [17,23]. 
 
 The overall goal of this project will be to build upon these achievements by 
targeting the filomicelles to the malaria parasite (P. yoelii 17XNL merozoites, a 
rodent-specific species of Plasmodium). The first step of which is to conjugate 





CHAPTER II  
LITERATURE REVIEW AND BACKGROUND 
 
This chapter includes reviews of articles on the two main topics of this 




2.1.1 Malaria Infection 
Five strains of malaria parasites constitute major health risks: P. falciparum, P. 
vivax, P. ovale, P. malariae, and P. knowlesi with P. falciparum being the most 
pathogenic and accounting for most malarial mortality [5,18]. The parasites 
exhibit a life cycle involving both an insect host and a vertebrate host. The sexual 
stages develop in the female Anopheles mosquitoes and the asexual stages take 
place in the mammalian host. 
 
Identification of infection by P. falciparum is usually based on the presence of 
small ring-stage parasites on blood smears [14]. Infected red blood cells are not 
enlarged, and multiple infections of a single red blood cell are common [5]. An 
important difference between P. falciparum and other human malarias is that 
maturing trophozoites are usually sequestered in the capillaries of internal 
organs, such as the heart, brain, spleen, skeletal muscles, and placenta, thus 
protecting them from being cleared rapidly by the spleen [33]. Red blood cells 
infected by P. vivax are enlarged and, when stained with Giemsa, often show 
stippling on the red blood cell membrane, known as Schüffner’s dots [34]. All 
stages of the P. vivax parasite are present in the peripheral circulation.  P. ovale 
infection produces a fever clinically similar to that of vivax malaria but somewhat 
less severe. P. malariae develop in the mosquito slowly, and infection in humans 
is not as intense as that caused by the other Plasmodium species [35].  Red 
blood cells infected with P. malariae remain the same size throughout 
schizozony. Infections by P. malariae and P. falciparum do not relapse. P.vivax 
and P. ovale infections produce the classic relapsing malaria, initiated from 
dormant parasites in the liver that have resumed development after a period of 
latency [32].  
 
Infected female mosquitoes transfer parasites into the subcutaneous tissue, and 
less frequently directly into the blood stream, after a mosquito bite [19]. The 
parasites are sporozoites (motile spore-like) at this stage of the infection, and 
they localize to parenchymal cells of the liver. The sporozoites then invade liver 
cells, where they replicate [30]. The length of this asexual division and the 
number of non-motile progeny (merozoites) produced within each infected cell is 
a characteristic of the individual species of Plasmodium. In general, over a period 
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of one to two weeks, the Plasmodium parasites produce and release thousands 
of merozoites per liver cell. Specifically, P. falciparum, for example, produces 
about 40,000 merozoites within one week. These merozoites then return to the 
bloodstream and invade red blood cells. The mechanism of invasion involves 
initial attachment of the parasite to the red blood cell, apical reorientation of the 
merozoite, tight junction formation between host and parasite, apical organelle 
secretion followed by host cell entry utilizing a moving junction between the 
parasite and the host cell membrane, marked by erythrocyte deformation, and 
then termination through resolution of ligand-receptor interactions by proteolytic 
cleavage [21]. In the red blood cells, the parasite begins to grow, first forming the 
ring-like early trophozoite, and eventually enlarging to fill the cell. The parasite 
then undergoes asexual division and becomes a schizont composed of 
merozoites. The parasites are nourished by the hemoglobin within the 
erythrocytes and produce a characteristic pigment called hemazoin. The cycle is 
completed when the red blood cell ruptures and releases newly formed 
merozoites into the bloodstream, leading to clinical infection. 
 
Many attempts to stop invasion have involved targeting merozoite surface 
proteins. The merozoite surface proteins are very diverse and polymorphic. Of 
these surface proteins, apical membrane antigen 1 (AMA1) has been identified 
as an essential gene for parasite invasion and survival within the human host 
[15]. I focus on targeting this protein. 
 
2.1.2 Apical Membrane Antigen 1 
Apical membrane antigen 1 (AMA1) of Plasmodium is a surface protein that is 
expressed in schizont-stage malaria parasite, sporozoites, and merozoites, and 
plays a crucial role in the invasion of both hepatocytes and red blood cells 
[12,24].  
 
Several peptides have been identified to bind to AMA1. These peptides include 
[10]: 
1. R1 (VFAEFLPLFSKFGSRMHILK) 
2. R3 (PVLRSGRCAELIQIGFRCRA) 
3. F1 (GWRLLGFGPASSFSM) 
Although AMA1 itself is also very polymorphic, it contains a conserved 
hydrophobic trough that all three peptides appear to bind [11], blocking merozoite 
invasion, even after initial attachment to the red blood cell surface [16,26]. In a 
study with multiple sequence alignment of the AMA1 amino acid sequences from 
six Plasmodium species (P. berghei, P. yoelii, P. chabaudi, P. vivax, P. knowlesi, 
and P. falciparum), 60% of the residues in this region of the protein are 
conserved across the Plasmodium  species including P. yoelii [1,12]. Therefore, 
these peptides are attractive candidates for targeting Plasmodium to reduce red 
blood cell invasion.  
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2.2 Filomicelles  
 
In this study, I propose to modify the surface chemistry of filomicelles with 
peptides that have been identified to bind malaria parasites. The long-term goal 
is to hamper the life cycle of malaria parasites by administering these 
functionalized filomicelles to mice infected with parasites. By functionalizing 
filomicelles with the above peptides, I aim to achieve specific targeting and retain 
the previous benefits of delivering hydrophobic drugs. The filomicelles used here 
have lengths of several microns and diameters of about fifty nanometers [4,27]. 
The flexibilities of the filomicelles are on the order of the diameter of malaria 
parasites. The most desirable strength of these fluid filomicelles is that they 
remain in the circulation of rodents ten-fold longer than spherical analogs and are 
more persistent than any known synthetic nanoparticle [6], providing an extended 
opportunity to bind circulating Plasmodium parasites.  
 
2.2.1 Degradable Filomicelles 
Filomicelles prepared from poly(ethylene oxide) - poly(ε-caprolactone)- 
copolymers (PEO-PCL) spontaneously shorten to generate spherical micelles 
due to chain-end hydrolysis of the caprolactone [7]. This characteristic can be 
used in controlled drug release [28]. 
 
2.2.2 Non-degradable Filomicelles  
Filomicelles prepared from non-degradable amphiphilic poly(ethylene oxide) - 
poly(butadiene) copolymers (PEO-PBD) are stable for years at 4C and can stay 
in circulation longer than spherical analogs [6], providing an extended opportunity 
to bind and engulf Plasmodium parasites. Both degradable and non-degradable 
filomicelles may prove effective at different times during the malaria parasite life 






MATERIALS AND METHODS 
  
3.1 Modified Filomicelles 
 
3.1.1 Filomicelles 
The filomicelles used here were assembled from diblock copolymers of poly-
ethylene oxide (PEO) with either poly-caprolactone (PCL) or poly-butadiene 
(PBD) as the hydrophobic block. PEO is FDA-approved for use in the body and 
PCL is biodegradable. PCL and PBD provide the structural stability of the 
filomicelles and PEO keeps the filomicelles soluble in aqueous environments. 
The PEO can also be modified for peptide attachment.  
 
In the beginning stages of my thesis, I perfected and scaled up the formation of 
PEO-PCL filomicelles. I am now able to obtain 50 ml’s of PEO-PCL filomicelles 
whereas before I had 1 ml of PEO-PCL filomicelles with many assembles that 
were not cylindrical. 
 
The following procedure was used to form filomicelles having parasite binding 
peptides. COOH-PEO-PBD was mixed with PEO-PCL where the carboxyl groups 
were exposed to the aqueous environment. The carboxyl groups react with 1-
ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) to form an 
unstable reactive ester intermediate (Figure 1). N-hydroxysulfosuccinimde (Sulfo-
NHS) and the peptide are then added to the reaction to form a filomicelle where a 
certain fraction of the COOH-PEO-PBD diblock copolymers have the new 






Figure 1. Schematic Diagram for Attaching Primary Amines to PEG.   
The symbol * on *PEO-PBD indicates where the carboxylate is located. 
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3.1.2 AMA1-Targetting Peptides 
Three peptides have been identified that bind AMA1 [10]. Of the three, R1 
contains lysine, which has the potential to form side products in our reaction 
scheme, which could reduce its affinity for AMA1 [11,13]. Therefore, I focused on 
conjugating R3 and F1 peptides to the exteriors of the filomicelles.  
 
3.1.3 Visualization Method 
Filomicelles were visualized by fluorescent microscopy using a hydrophobic dye 
(PKH26) [2,3]. After formation of the filomicelles, 1 μL of 1 mM PKH26 dye in 
ethanol was added to a 1 mg/ml sample of PEO-PCL filomicelles. Since the dye 
is hydrophobic, it partitions into the cores of the filomicelles. PKH26 dye remains 
in the cores of non-degradable PEO-PBD filomicelles for up to one week in the 
plasma of rodents after tail-vein injection.       
 
3.1.4 Bovine Serum Albumin 
Before working with the above peptides, I wished to attach a readily available 
biomolecule to the filomicelles. Bovine serum albumin (BSA) was chosen 
because it has multiple exposed lysines and is inexpensive. I attached BSA to 
the filomicelles using the method described in section 3.1.1. Coomassie staining 
was used to quantify the amount of BSA bound to the filomicelles.  
 
3.1.5 Electrophoresis 
Analysis of SDS-page gels was used to show covalent binding of F1 peptide to 
the COOH-PEO-PBD copolymer.  
 
3.1.6 Fluorescence Microscopy and Spectroscopy with Alexa Fluor 
To determine attachment of R3 to the filomicelles, cysteines on R3 were labeled 
with a fluorescent maleimide molecule. The fluorescence of the samples was 




3.2 PEO-PCL Filomicelle Degradation 
 
3.2.1 Scanning Transmission Electron Microscopy (STEM) 
A major question in the field of drug delivery is how the structural integrity of drug 
delivery vehicles is affected by the deposition of plasma proteins on the surface 
of the vehicles. To help address this question, I monitored the morphology 
changes of filomicelles in aqueous media and then in the presence of serum 
proteins. 
 
Negative staining is a qualitative method for examining the structure of isolated 
organelles, individual macromolecules and viruses at the nano scale. Here, I 
imaged filomicelles using negative staining under an electron microscope. 
Observation of differences on the surface and in shape from degradation was 
made to qualitatively determine stability of the filomicelles. Since PCL degrades 
over time, an aging study on the PEO-PCL filomicelles was conducted and the 
morphology changes of the filomicelles, possibly due to hydrolysis [7], were 
observed. PEO-PBD filomicelles were used as a control.  
 
3.2.2 Chromatography 
Ion-exchange chromatography was used in the separation of filomicelles and 
proteins contents introduced in the studying of filomicelle stability in presence of 
high protein environment. Source Q resin was used to separate filomicelles and 
preliminary tests are done using bovine serum albumin (BSA) in solution. 
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CHAPTER IV  
RESULTS AND DISCUSSION 
 
 This chapter includes the results and discussion from the experiments 
where filomicelles were modified with a test protein, bovine serum albumin 
(BSA), and then with AMA1-binding peptides, R3 and F1 (section 4.1). Also 
included are the in vitro experiments studying PEO-PCL and PEO-PBD stability 
using STEM (section 4.2).   
 
4.1 Modified Filomicelles 
 The chemicals EDC and Sulfo-NHS were used to modify the carboxylic 
acid ends of the COOH-PEO-PBD copolymers so that the primary amine of a 
peptide could form a stable covalent bond to the filomicelle. This chemistry is 
used widely in immobilization procedures and immunogen preparation (attaching 
a small peptide to a large carrier protein). Several experiments were carried out 
to test for stable attachment. The morphology of the modified filomicelles was 
also observed in select cases. 
 
4.1.1 Bovine Serum Albumin (BSA) attachment to filomicelles 
BSA was attached to filomicelles using the chemistry scheme shown in Figure 1. 
Two filomicelle samples were formed. In both samples, 99% of the copolymers 
were PEO-PCL and 1% were COOH-PEO-PCL. For the first sample, the above 
chemistry scheme was used to attach BSA through its N-terminus or lysine 
groups. For the second sample, only BSA was added and EDC and Sulfo-NHS 
were omitted. 
 
Both samples were stained with Bradford and showed comparable signals 
(Figure 2). BSA that had not bound the filomicelles was then removed by dialysis 
overnight. The Bradford signal of the second sample was reduced by a factor of 
four and was much lower than the signal of the first sample (Figure 2). This 
suggests that BSA was covalently attached to the modified carboxyl group on the 
end of the COOH-PEO-PBD copolymer. 





Figure 2. Attachment of BSA to filomicelles. 
Modified filomicelles with BSA attachments before dialysis (A), modified filomicelles with 
BSA attachments after dialysis (B), regular filomicelles with BSA in solution before 




4.1.2 Modified Filomicelles with R3 and F1 peptides 
Unfortunately, using Bradford or equivalent stains to determine whether 
biomolecules are present on filomicelles was unsuccessful because the signal to 
noise ratio is too low to be detected by spectrophotometers. To overcome this 
issue, SDS-Page gels were used to determine whether covalent peptide 
attachment to filomicelles was successful. After performing the chemistry scheme 
shown in Figure 1 with the F1 peptide, the products were run on an SDS-page 
gel. The band for unbound peptide can be seen in lane 1; two bands can be seen 
in lane 2; and a light but broad band can be seen in lane 3 (Figure 3). I postulate 
that the lower band in lane 2 is peptide conjugated to copolymer and the upper 
band in lane 2 represents filomicelles that have peptide bound but have not 
broken up completely. It is not yet understood why the filomicelles appear in lane 
3 because they are not charged. 
 
An additional technique that can be used to determine if biomolecules have 
bound filomicelles is to label the biomolecules with a fluorescent probe. 
Fluorescent maleimide molecules can be used for this purpose if the 
biomolecules have solvent-exposed cysteines. I used this scheme to determine if 
R3 peptide (PVLRSGRCAELIQIGFRCRA), which contains two cysteines, was 
covalently attached to the filomicelles after using the chemistry scheme of Figure 
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1. After formation of two sets of filomicelles with 0.1% COOH-PEO-PBD and 
99.9% PEO-PCL, the chemistry scheme described in Figure 1 was used to 
attach R3 to the modified COOH in the first set of filomicelles. EDC and sulfo-
NHS were not added to the second set of filomicelles. A fluorescent maleimide 
(λ=556) was introduced to both samples. The first set of filomicelles had a 2-fold 
increase in fluorescence over the control. Fluorescent microscopy images reveal 
similar results (Figure 4). 
 
It is not clear why the difference in fluorescence between the two samples was 
so low. One possibility is that the modified COOH group is not well exposed on 
the PEO brush because the COOH-PEO group is shorter than the PEO group on 
the other 99.9% of the copolymers. Graduate student Kevin Quigley is currently 




Figure 3. SDS-Page gel 
showing F1 peptide 
Attachment.  
Ladder, F1 peptide, modified 
filomicelles with F1 peptide, 
and regular filomicelles. 
 
Figure 4. Fluorescent microscopy images showing 
R3 peptide Attachment. 
Filomicelles with R3 covalently bound to the COOH-
PEO-PBD groups were incubated with Alexa Fluor 
maleimide, which binds the cysteines of R3. (A-C) 
Fluorescent micrographs of (A) R3-filomicelles after 
incubation with the reactive fluorophore, (B) same as 
(A) but with PKH26 dye added, (C) Unreactive 
filomicelles after incubation with the reactive 
fluorophore (control for (A)), and (D) same as (B) but 





4.2 Filomicelles as a Model System to Study Drug Delivery 
Vehicle Degradation 
 
4.2.1 Filomicelle Aging Study  
For a drug delivery vehicle to be effective it must maintain its structural integrity 
in the body. Vehicles that fall apart and leak their contents before reaching the 
target area in the body are of limited efficacy and can cause side effects. To 
address this issue, the morphology changes of filomicelles over time were 
observed using electron microscopy. Electron micrographs showed 
morphological changes in areas that were degrading presumably due to 
hydrolysis of the PCL in the filomicelle (Figure 5). Over time, hydrolysis continues 
to shorten the PCL to the extent that the copolymer then favors spherical 
conformation [7], which results in the disappearance of cylindrical micelles and 





Figure 5. PEO-PCL Filomicelles Degradation. 
Filomicelles are represented with blue hydrophilic regions and red hydrophobic regions. 
The yellow spheres represent dye or drug molecules that can be embedded for delivery. 
The life of PEO-PCL filomicelles starts with filomicelles with smooth contour (day 1 or 
t=0 hours). By day 5, t=96 hours, most of the filomicelles show dark areas surrounding 
edges and corners, which would be the means for the drug (yellow spheres), embedded 
to leave the carrier. By day 11, t=240 hours, most of the filomicelles have disappeared, 





4.2.2 Accelerated Degradation in High BSA Concentration 
I ultimately wish to determine rates of filomicelle morphological changes in 
physiologically relevant situations. To this end, I incubated filomicelles with 
serum proteins. Two sets of filomicelles were formed: one set was incubated in 
20 mM Tris-HCl buffer, and a second set was incubated in the same buffer with 
0.05 mM BSA. Samples were run through Source Q resin to remove unbound 
proteins (the worms flow past the beads and do not bind). This was done to clear 
the samples of large proteins, which complicate electron micrograph 
interpretation. Comparing the two sets of samples suggests that presence of 
BSA accelerates rate of filomicelle aging by day 3, t=48 hours (Figure 6). The 
sample with BSA resembles the disappearance of cylindrical micelles and 
appearance of many spherical micelles in the sample by day eleven from the 
previous study in water. This implies that the morphology change of the 
filomicelles would be accelerated when injected and tested in vivo; therefore, 
more studies to determine the effects of protein deposition and shear on 
filomicelle morphology and stability is needed to prevent premature release of 





Figure 6. Day 3 PEO-PCL filomicelles in 20 mM Tris-HCl and BSA 
Filomicelles in 20 mM Tris-HCl buffer (left pannel). Filomicelles in the presence of 0.05 




CHAPTER V  
CONCLUSIONS AND RECOMMENDATIONS 
 
My thesis focused on optimizing the covalent conjugation peptides to the 
exteriors of filomicelles. The peptides were previously identified to bind apical 
membrane antigen 1 (AMA1), which is expressed on the surface of malaria 
parasites. I also used high-resolution microscopy techniques to determine 
changes in filomicelle morphology over time in aqueous media and with the 
addition of serum proteins. 
 
BSA, R3, and F1 peptides were reacted with the filomicelles and their 
attachment was checked with Bradford, SDS-Page, and cysteine-maleimide 
chemistry. 
 
In the second project, electron micrographs of aging PEO-PCL filomicelles 
reveal unraveling and multi-location degradation over several days in water. 
Electron micrographs of PEO-PCL filomicelles incubated with BSA concentration 
shows higher degradation rate, but similar degradation pattern. In the future, this 
study will extend to monitoring filomicelle structure in plasma and finally live 
animals. 
 
Two in vivo experiments in the Schmidt Lab are proposed for future testing 
the effectiveness of R3- and F1-filomicelles in the mouse model of the disease. 
The first is to mix the filomicelles with infected red blood cells (iRBC) and co-
inject this mixture into C57BL/6 mice. If the number of parasites is reduced in 
subsequent blood samples, it will show that filomicelles may be effective in 
blocking the parasites’ replication cycle. The second experiment will be to inject 
filomicelles into mice that are already infected with the parasite. Again, the 
number of parasites in circulation will be quantified to determine if filomicelles are 
appropriate for reducing their replication. In both cases I am hoping for binding of 
filomicelles to the parasites through the R3-AMA1 and F1-AMA1 interactions 








Figure 7. Mechanism of binding malaria parasites by modified filomicelles 
The more stable PEO-PBD filomicelles, are expected to bind and ensnare the merozoite 
(A), and the degradable PEO-PCL filomicelles can be loaded with anti-malarial drugs, 
and are expected to breakdown and release the drugs (shown in yellow) after localizing 
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Appendix I. Electron Micrographs of PEO-PCL Hydrolysis in vitro 
Each of the samples has been examined as described in section 3.2.1. “Day 1 
samples” refer to the samples examined on the day the filomicelles were formed, 
thus are also samples at t=0 hours. “Day 3 samples” refer to the samples 
examined on the third day after the filomicelles were formed, thus are also 






































Appendix II. Supporting Data 
 
 
Table 1. Protein Bradford Data 
 Protein Bradford with BSA Data 
Sample With/Before With/After Without/Before Without/After 
1 0.019 0.014 0.020 0.000 
2 0.020 0.015 0.016 0.001 
3 0.018 0.015 0.017 0.003 
4 0.019 0.016 0.015 0.002 
5 0.018 0.013 0.018 0.000 
6 0.017 0.012 0.019 0.001 
7 0.017 0.016 0.017 0.001 
8 0.018 0.017 0.016 0.002 
9 0.017 0.014 0.019 0.002 
10 0.018 0.013 0.020 0.003 
Mean 0.018 0.015 0.018 0.002 
 
 
Table 2. PCL Filomicelle (Worm) Experiment with Alexa Fluor. 
Sample Abs 







worm with peptide and fluor 0.296 1.92 2.25 
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